As an industry leader in antibody engineering field, experts from Creative Biolabs has developed CeativeAbTM antibodies in order to increase the efficacy of current therapeutic antibodies. Bispecific antibodies (BsAbs) are bioengineered antibodies that contain two different binding sites within a single molecule, which can specifically bind two different types of antigen. The most widely used application of bi-specific antibody is in cancer immunotherapy, which create a therapeutic treatment approach for diseases with specific medical needs.